Literature DB >> 30768314

Chiral Interactions up to Next-to-Next-to-Next-to-Leading Order and Nuclear Saturation.

C Drischler1,2, K Hebeler1,2, A Schwenk1,2,3.   

Abstract

We present an efficient Monte Carlo framework for perturbative calculations of infinite nuclear matter based on chiral two-, three-, and four-nucleon interactions. The method enables the incorporation of all many-body contributions in a straightforward and transparent way, and makes it possible to extract systematic uncertainty estimates by performing order-by-order calculations in the chiral expansion as well as the many-body expansion. The versatility of this new framework is demonstrated by applying it to chiral low-momentum interactions, exhibiting a very good many-body convergence up to fourth order. Following these benchmarks, we explore new chiral interactions up to next-to-next-to-next-to-leading order (N^{3}LO). Remarkably, simultaneous fits to the triton and to saturation properties can be achieved, while all three-nucleon low-energy couplings remain natural. The theoretical uncertainties of nuclear matter are significantly reduced when going from next-to-next-to-leading order to N^{3}LO.

Entities:  

Year:  2019        PMID: 30768314     DOI: 10.1103/PhysRevLett.122.042501

Source DB:  PubMed          Journal:  Phys Rev Lett        ISSN: 0031-9007            Impact factor:   9.161


  2 in total

1.  Constraining neutron-star matter with microscopic and macroscopic collisions.

Authors:  Sabrina Huth; Peter T H Pang; Ingo Tews; Tim Dietrich; Arnaud Le Fèvre; Achim Schwenk; Wolfgang Trautmann; Kshitij Agarwal; Mattia Bulla; Michael W Coughlin; Chris Van Den Broeck
Journal:  Nature       Date:  2022-06-08       Impact factor: 69.504

2.  Ab initio predictions link the neutron skin of 208Pb to nuclear forces.

Authors:  Baishan Hu; Weiguang Jiang; Takayuki Miyagi; Zhonghao Sun; Andreas Ekström; Christian Forssén; Gaute Hagen; Jason D Holt; Thomas Papenbrock; S Ragnar Stroberg; Ian Vernon
Journal:  Nat Phys       Date:  2022-08-22       Impact factor: 19.684

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.